24 participants
Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Genetic Changes (MATCH-Subprotocol N)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-27
- Start Date:
- 2016-05-05
- Completion:
- 2020-11-10
Conditions
- Advanced Lymphoma
- Advanced Malignant Solid Neoplasm
- Hematopoietic and Lymphoid Cell Neoplasm
- Refractory Lymphoma
- Refractory Malignant Solid Neoplasm
- Refractory Multiple Myeloma
Interventions
- DRUG